Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.28 - $0.75 $443 - $1,188
-1,585 Reduced 8.8%
16,424 $5,000
Q2 2023

Aug 14, 2023

SELL
$0.52 - $0.76 $2,054 - $3,002
-3,951 Reduced 17.99%
18,009 $10,000
Q1 2023

May 15, 2023

SELL
$0.56 - $1.15 $1,176 - $2,415
-2,100 Reduced 8.73%
21,960 $12,000
Q4 2022

Feb 14, 2023

SELL
$0.54 - $21.75 $23,371 - $941,340
-43,280 Reduced 64.27%
24,060 $16,000
Q3 2022

Nov 14, 2022

BUY
$1.23 - $21.9 $82,828 - $1.47 Million
67,340 New
67,340 $98,000
Q4 2021

Feb 14, 2022

SELL
$6.04 - $8.03 $182,534 - $242,674
-30,221 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$8.02 - $11.0 $135,128 - $185,339
-16,849 Reduced 35.8%
30,221 $159,000
Q2 2021

Aug 16, 2021

BUY
$7.59 - $10.48 $259,691 - $358,573
34,215 Added 266.16%
47,070 $279,000
Q1 2021

May 17, 2021

BUY
$6.86 - $9.24 $88,185 - $118,780
12,855 New
12,855 $91,000

About Cyclacel Pharmaceuticals, Inc.


  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $7.9M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.